Optimize study design for pediatric patients.

Improve study outcomes for pediatric therapies by addressing the needs of children and their families – from formulations to biospecimen requirements.

Expertise from start to finish

Pediatric expertise is essential to developing and commercializing pediatric therapies, from the earliest planning stages through launch and real-world assessment. With our Pediatric Center of Excellence, we provide a range of scientific, therapeutic, regulatory, and operational expertise to ensure study success. These resources extend beyond IQVIA to encompass a global network of top performing sites, ensuring there are sites around the world with the proven ability to conduct every pediatric clinical trial.

Experienced team and trusted networks

• IQVIA’s medical, R&D, and operational teams offer expertise across multiple therapeutic areas.
• Pediatric and Rare Disease Network accelerates enrollment and promotes collaboration among sites in multiple regions.
• Navigate regulatory requirements by age and country and collaborate on protocol writing.
• Pediatric Early Phase Oncology Network develops KOL and PI relationships at high-performing sites about pediatric studies feasibility, design, start-up, and more.
• Innovative direct to patient recruiting approaches, including digital, capitalize on social listening and community outreach.

Understanding of patient and family needs

Successful pediatric trial designs are attentive to the needs of infant, child, or adolescent patients. And decision making about study participation typically involves multiple family members. IQVIA considers the differences within pediatric sub-populations and takes a sensitive approach to these patients and their caregivers.

Facts

Independent Audits Conduct thorough independent audits of study documents and processes to identify specific pediatric considerations and safeguard the well-being of children in research. Pediatric Pharmacokinetic Services Utilize pharmacokinetic modeling and simulations to minimize lab procedures for children, which reduces anxiety and increases retention. Child-Appropriate Drug Formulations Drug formulations that are palatable to young children, such as dispersible and mini tablets, improve adherence and safety among patients. Clinical Trial Educators IQVIA CTEs help onboard patients into studies, share expertise, and advocate for them and their families, which improve outcomes. Hybrid and Decentralized Trials Offer the flexibility and convenience of hybrid and decentralized clinical trial modalities to reduce burden for pediatric patients and their families. Consent Regulations by Country Navigate the landscape of consent regulations that vary by age and country, and demonstrate concern for patient rights, privacy and custody issues. Patient Advocacy Groups Collaborate with PAGs to raise study awareness and facilitate patient and family participation in aspects of studies including protocol design and relevant endpoints.